News

Vivos Therapeutics Celebrates New Sleep Center Launch in Michigan

Vivos Therapeutics Celebrates New Sleep Center Launch in Michigan

Exciting News from Vivos Therapeutics, Inc.

In a recent announcement, Vivos Therapeutics, Inc. (NASDAQ: VVOS), a prominent player in the healthcare sector focusing on sleep-related issues, has proudly revealed the grand opening of a new sleep testing and treatment center near Detroit. This facility marks another step in Vivos’ mission to provide innovative solutions for individuals suffering from obstructive sleep apnea (OSA) and related conditions.

Expanding the Reach of Vivos' Innovative Solutions

The newly opened center in Auburn Hills represents a continuation of Vivos’ strategic expansion through a unique sleep center affiliation model. This approach has proven to be a cost-effective and scalable means of extending Vivos’ operations beyond their original base in Las Vegas, Nevada. In this model, Vivos forms contractual alliances with existing sleep centers, rather than solely focusing on acquisitions. This allows them to retain the benefits of their proprietary diagnostic and therapeutic products while minimizing capital expenditures.

The Vision Behind the Expansion

Kirk Huntsman, Chairman and CEO of Vivos, highlighted the rationale behind their expansion strategy. The sleep disorder treatment landscape has faced significant challenges due to mounting pressure on pricing from insurance companies, resulting in the closure of many sleep labs or mergers with larger organizations. Vivos aims to offer a refreshing alternative perspective and treatment options through its collaboration with established sleep centers. This partnership model not only supports the providers but also enhances patient care by offering more comprehensive and effective therapies.

Enhancements for Patient Care

The grand opening in Michigan follows Vivos’ arrangement with MISleep Solutions, LLC, earlier in the year. This partnership enables Vivos to deliver essential management and support services alongside its full range of innovative treatments designed to combat OSA. The focus has been on building well-equipped facilities, employing trained staff, and ensuring optimal care for patients. This less capital-intensive strategy allows Vivos to provide high-quality treatment options while ensuring the financial sustainability of their operations.

Innovative Technology at the Heart of Treatment

Vivos Therapeutics stands at the forefront of medical technology with its range of devices developed for addressing complex breathing and sleep issues. Their groundbreaking Complete Airway Repositioning and Expansion (CARE) devices are FDA-approved and have revolutionized the approach to treating severe OSA, being the first of their kind authorized for use in children.

A Global Health Concern

Currently, OSA affects over a billion people globally, yet statistics indicate that a staggering 90% of those with the condition remain undiagnosed. This chronic disorder extends beyond mere sleep disturbances; it is intricately linked to numerous serious health conditions. While traditional solutions like CPAP have dominated the landscape for many years, they often miss addressing the underlying causes of OSA.

Vivos' Vision for the Future

Since its establishment in 2016, Vivos has dedicated itself to reshaping how healthcare professionals manage OSA and similar breathing disorders. Their innovative approaches combine technology with educational frameworks to facilitate better care for patients. Vivos calls this approach The Vivos Method, which encapsulates a non-surgical, non-invasive, and non-pharmaceutical solution designed to inspire hope and transformation in patients’ lives.

Future Collaborations and Growth

In addition to the recent partnership with MISleep Solutions, Vivos is actively seeking opportunities to collaborate with various sleep centers and specialists nationwide. By expanding their network and continuing to innovate, Vivos aims to reach and help a myriad of patients struggling with OSA.

Frequently Asked Questions

What is the primary focus of Vivos Therapeutics?

Vivos Therapeutics focuses on diagnosing and treating sleep-related breathing disorders, specifically obstructive sleep apnea.

Where is the new Vivos sleep center located?

The new sleep center is located in Auburn Hills, near Detroit.

How does Vivos’ operational model benefit patients?

The model allows for capital-efficient expansion while providing patients access to advanced treatment options through partnerships with existing sleep centers.

What are CARE devices?

CARE devices are FDA-cleared technologies developed by Vivos specifically to treat severe obstructive sleep apnea in adults and children.

What is The Vivos Method?

The Vivos Method offers a non-invasive, clinically effective treatment for OSA, empowering patients to achieve better sleep health.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 43

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming Lives: A Look at Xinjiang's Aratax Dam Project

Updated Category News Views 287

Transforming Communities Through the Aratax Dam In the mountainous region where the Yarkand River flows, there was a time when residents faced severe challenges during the rainy season. Flooding was a frequent and destructive occurrence, threatening homes, crops, and entire communities. The memories of such natural disasters still linger in the minds of locals. However,...

Continue Reading
Join Securitas for an Insightful Capital Markets Day in 2026

Updated Category News Views 208

Join Securitas for an Insightful Capital Markets Day in 2026 Mark your calendars for June 16, 2026, as Securitas extends a warm invitation to investors, analysts, and financial media for its much-anticipated Capital Markets Day. This significant event will unfold at the prestigious London Stock Exchange, offering attendees a detailed overview of Securitas' strategic...

Continue Reading
Discover High-Yield Monthly Dividend Funds for a Bright 2025

Updated Category News Views 213

The Allure of Closed-End Funds and Their Yields Many investors find closed-end funds (CEFs) attractive primarily due to their impressive dividends. The average yield of 8.7% offered by these funds can play a significant role in retirement planning, ensuring a steady income stream. Besides the attractive yields, CEFs provide access to a diverse array of assets, such as...

Continue Reading
Investors Alert: Class Action Opportunities for Major Companies

Updated Category News Views 118

Understanding Class Action Lawsuits Class action lawsuits serve as an important tool for investors who believe they have suffered significant losses due to fraudulent activities of publicly traded companies. These lawsuits not only provide a collective approach to seeking justice but also offer an opportunity for shareholders to hold companies accountable for misleading...

Continue Reading
Davidson Kempner Analysis of Aviva's Shareholding Trends

Updated Category News Views 267

Understanding Davidson Kempner Capital Management LP's Position on Aviva plc In a recent disclosure, Davidson Kempner Capital Management LP made significant waves regarding their positions in Aviva plc. Attention has been drawn to their practices as they hold a considerable stake in the company. Key Information from the Disclosure The form provides essential information...

Continue Reading